With a staggering 7.63% dividend yield, Pfizer (NYSE: PFE ) is a mouth-watering candidate for income-seeking investors. But is this high yield stock a trap that is too good to be true, or is it a genuine opportunity?I am a conservative yet opportunistic value investor who has been investing since 2005. I am fact-driven, preferring to let financial data inform me of a company's health, followed by qualitative analysis to fill in the gaps to paint a holistic picture of a company's growth prospects.My work is ...